References
- BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52(supp 5):S1–28.
- Chung KF, Adcock IM. Multifaceted mechanisms in COPD: Inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008; 31:1334–1356.
- Cosio MG, Saetta M, Agusti A. Immunological aspects of chronic obstructive pulmonary disease. N Engl J Med 2009; 360:2445–2454.
- MacNee W, Donaldson K. Mechanism of lung injury caused by PM10 and ultrafine particles with special reference to COPD. Eur Respir J 2003; 21 suppl:47s–51s.
- Lawesa CMM, Thornley S, Young R, Statin use in COPD patients is associated with a reduction in mortality. Prim Care Respir J 2011; 20:35–40.
- Pearson M. Statins for COPD: A challenge to conventional beliefs? Prim Care Respir J 2012; 21:5–7.
- Surgeon General, U.S. Public Health Service. The health consequences of smoking. Cancer and chronic obstructive lung disease in the workplace. A report of the Surgeon General. U.S. Office on Smoking and Health, Rockville, MD, 1985.
- Zhu BQ, Parmley WW. Hemodynamic and vascular effects of active and passive smoking. Am Heart J 1995 Dec; 130(6):1270–1275.
- Fraser RG, Pare P, Pare J, Fraser RS, Genereux G. The normal chest. In Fraser RG, Pare P, Pare J, Fraser RS, Genereux G, editors, Diagnosis of Diseases of the Chest. W.B. Saunders: Philadelphia, PA, 1988, pp. 79–83.
- Pearson MG, Chamberlain MJ, Morgan WKC, Vinitski S. Particle deposition in the lung during cigarette smoking. J Appl Physiol 1985, 59:1828–1833.
- U.S. National Research Council. 10. Tobacco Smoke and Toxicology. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. The National Academies Press, Washington, DC, 2001.
- Heath D, Harris R. The Human Pulmonary Circulation. Churchill Livingstone: London, 1977, p. 601.
- West JB. Ventilation/Blood Flow and Gas Exchange. Blackwell: Oxford, UK, 1977.
- Schwab JM, Nguyen TD, Meyermann R, Schluesener HJ. Human focal cerebral infarctions induce differential lesional interleukin-16 (IL-16) expression confined to infiltrating granulocytes, CD8+ T-lymphocytes and activated microglia/macrophages. J Neuroimmunol 2001; 114:232–224.
- Matsuba K, Thurlbeck WM. The number and dimensions of small airways in emphysematous lungs. Am J Pathol 1972; 67:265–275.
- McDonough JE, Yuan R, Suzuki M. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011; 365:1567–1575.
- Washko GR, Hunninghake GM, Fernandez IE, Nishino M, Okajima Y, Yamashiro T, Ross JC, Estépar RS, Lynch DA, Brehm JM, Andriole KP, Diaz AA, Khorasani R, D'Aco K, Sciurba FC, Silverman EK, Hatabu H, Rosas IO, COPD Gene Investigators. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 2011; 364:897–906.
- Morgan MD, Edwards CW, Morris J, Matthews HR Origin and behaviour of emphysematous bullae. Thorax 1989; 44:533–538.
- Schwartz J. A spine for our time. Thorax 2011; 66:841–842.
- Rogan JM, Attfield MD, Jacobsen M, Rae S, Walker DD, Walton WH. Role of dust in the working environment in development of chronic bronchitis in British coal miners. Br J lnd Med 1973; 30: 217–226.
- Xu X, Laird N, Dockery DW, Schouten JP, Rijcken B, Weiss ST. Age, period, and cohort effects on pulmonary function in a 24-year longitudinal study. J Epidemiol 1995; 141:554–566.
- Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years observation on male British doctors. BMJ 1994; 309:901–910.
- Spence DPS, Hay JG, Carter J, Pearson MG, Calverley PMA. The effect of anticholinergic bronchodilatation on oxygen saturation and breathlessness in chronic obstructive pulmonary disease. Thorax 1993; 48:1145–1150.